SCRI is the only oncology research organization of its kind to offer end-to-end clinical trial site management, contract research services for biopharma and personalized medicine advisory services in one place. As a leader in drug development, SCRI has conducted nearly 750 first-in-human trials to date. More than 4,500 patients enroll to our early and late-phase trials every year.
Scientific Key Opinion Leaders
Faculty of physicians who oversees optimal execution of all aspects of clinical research
Oncology-Focused CRO
Designs and deploys trials to sites to assess and monitor the safety and efficacy of new treatments
Centralized SMO
Oversees a network of sites where physicians enroll and treat patients on clinical trials with full trial operations support
Personalized Medicine
Informs targeted treatment and trial strategies for patients based on real-world data
Oncology-Focused Contract Research Organization (CRO):
Contracted by biopharma to design, manage and monitor trials as well as analyze results
From Pre-Clinical to Post-Approval, SCRI Development Innovations delivers end-to-end CRO capabilities:
- As a part of SCRI, we leverage expert physician expertise to design and implement clinical trials to advance therapies and improve the lives of patients fighting cancer.
- We work in tandem with SCRI’s centralized SMO to design and deliver timely site activation, patient recruitment and overall study delivery.
- Powered by Genospace’s precision medicine technology, our personalized medicine expertise informs clinical development approaches every step of the way.
- Clinical Development
- Strategic Planning & Oversight
- Clinical Monitoring
- Medical Monitoring
- Medical Writing & Publishing
- Pharmacovigilance
- Regulatory Affairs
- Data Management
- Project Management
- Biostatistics
Differentiators:
- Strategic Site Relationship & Expedited Start-up – We’re able to leverage existing relationships and infrastructure with SCRI sites to achieve expedited start-up in as little as 6 weeks
- Unique Personalized Medicine & Data Capabilities – SCRI’s Personalized Medicine program offers scientific consultative services to drug development partners to enrich clinical development insights
385+
- 47 Active Industry Sponsored Trials
- 28 Active Investigator Initiated Trials
55+
first-in-human trials conducted
25+
first-in-class trials conducted
CRO with Roots in Cancer since 2006
Centralized Site Management Organization:
Partner with a network of sites where physicians enroll and treat patients on clinical trials:
- SCRI’s Site Management Organization (SMO) offers operational and other centralized research support services for sites on phase I through III industry-sponsored and investigator-initiated trials.
- The SMO offers support services for trials across tumor types including highly specialized expertise in complex GI, lung, breast/gynecologic, central nervous system, genitourinary, melanoma and blood cancers. Additionally, the SMO works with FACT-accredited transplant sites to advance cellular therapy research inclusive of CAR T-Cell, CRISPR and other novel approaches.
SCRI Centralized Site Support Services
Menu management & accelerated start up
Regulatory
Budget, contract, and financial services
Protocol operations
Global quality & education
Technology integration & support
Financial planning & analysis
Our Differentiators:
- Rapid study activation timelines
- Community clinic-based model at SCRI sites provides access to larger numbers of patients
- Efficiencies with budget, contract, and informed consent
- Utilization of central IRBs
- Standardized SOPs and quality metrics across all SCRI sites
- Partners with the Personalized Medicine team to rapidly identify patients for trials
Personalized Medicine
Leverages real-world data to advise physicians and biopharma on clinical development and treatment planning
Leverages patient data to inform clinical development patient strategies
- Powered by cloud-based precision medicine technology developed by Genospace that transforms patient data into actionable insights
- Informs trial design, trial matching, optimal treatment recommendations for patients and population diversification
Genospace combines rich data sources with powerful technology to make biomedical data useful and usable, enabling the convergence of clinical research and clinical care.
Personalized Medicine Program Includes:
Site Support
- Patient-Centric Clinical Trial Matching
- Molecular Cancer Conferences: SCRI’s Molecular Tumor Boards
- MolecularHelp Consultation: On Demand Reviews of NGS Reports
- Molecular Education
- Variant Annotation
- Clinical Trial incl/excl criteria
- Drug MOA sensitivity
Partner Support
- Feasibility Analysis
- Real World Data Analytics
- Data-driven Study Design
- On Study Analytics
- Scientific Consultative Services